-
-
-
A412177-10mgInformationAsapiprant (S-555739) is a potent and selective antagonist for DP1 receptor with Ki of 0.44 nM.
-
A412177-1mgInformationAsapiprant (S-555739) is a potent and selective antagonist for DP1 receptor with Ki of 0.44 nM.
-
A412177-25mgInformationAsapiprant (S-555739) is a potent and selective antagonist for DP1 receptor with Ki of 0.44 nM.
-
A412177-50mgInformationAsapiprant (S-555739) is a potent and selective antagonist for DP1 receptor with Ki of 0.44 nM.
-
A412177-5mgInformationAsapiprant (S-555739) is a potent and selective antagonist for DP1 receptor with Ki of 0.44 nM.
-
A414054-100mgInformationAsciminib (ABL001) is a potent and selective allostericABL1inhibitor with dissociation constant (Kd) of 0.5-0.8 nM and selectivity to the myristoyl pocket of ABL1.TargetsAbl1 (Cell-free assay) 0.45 nMIn vitroABL001 is a potent, selective
-
A414054-10mgInformationAsciminib (ABL001) is a potent and selective allostericABL1inhibitor with dissociation constant (Kd) of 0.5-0.8 nM and selectivity to the myristoyl pocket of ABL1.TargetsAbl1 (Cell-free assay) 0.45 nMIn vitroABL001 is a potent, selective
-
A414054-25mgInformationAsciminib (ABL001) is a potent and selective allostericABL1inhibitor with dissociation constant (Kd) of 0.5-0.8 nM and selectivity to the myristoyl pocket of ABL1.TargetsAbl1 (Cell-free assay) 0.45 nMIn vitroABL001 is a potent, selective
-
A414054-50mgInformationAsciminib (ABL001) is a potent and selective allostericABL1inhibitor with dissociation constant (Kd) of 0.5-0.8 nM and selectivity to the myristoyl pocket of ABL1.TargetsAbl1 (Cell-free assay) 0.45 nMIn vitroABL001 is a potent, selective
-
A414054-5mgInformationAsciminib (ABL001) is a potent and selective allostericABL1inhibitor with dissociation constant (Kd) of 0.5-0.8 nM and selectivity to the myristoyl pocket of ABL1.TargetsAbl1 (Cell-free assay) 0.45 nMIn vitroABL001 is a potent, selective